+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Armagen  - logo

ArmaGen is a privately held, clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Currently, ArmaGen has eight compounds in development. The company’s lead product candidates are AGT-182 for Hunter syndrome, which is in Phase 1 clinical trials, and AGT-181 for Hurler syndrome, which is in Phase 2 trials. ArmaGen’s headquarters and research operations are located in Calabasas, CA.

From
From
From
From
From
From
From
From
From
From
Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • November 2017
  • 213 Pages
From
Loading Indicator
adroll